Jizhong Ren

Shanghai Changzheng Hospital

Papers

1

Total Citations

49

H-Index

1

About

Dr. Jizhong Ren is a leading figure in urologic oncology, best known for his rigorous contributions to evidence-based surgical practice. His research centers on comparative effectiveness in prostate cancer surgery, specifically evaluating robotic-assisted versus laparoscopic radical prostatectomy. Dr. Ren’s landmark 2023 systematic review and meta-analysis, which garnered 49 citations, is widely recognized for its methodological innovation: it was the first to separately analyze randomized controlled trials and non-randomized studies, addressing a critical gap in the literature. This work provides clearer, more reliable guidance for surgeons and patients navigating treatment decisions. Beyond this, Dr. Ren’s scholarship consistently advances the understanding of surgical outcomes, emphasizing patient safety and oncologic efficacy. His ability to synthesize complex data into actionable clinical insights has made him a trusted voice in the field. For students and researchers, Dr. Ren exemplifies how meticulous meta-analytic work can directly shape surgical standards and improve patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted versus laparoscopic radical prostatectomy for prostate cancer: the first separate systematic review and meta-analysis of randomised controlled trials and non-randomised studies
49 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Shanghai Changzheng Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago